Cassava Sciences: Conducting Two Randomized, Placebo-Controlled Phase 3 Clinical Trials Oral Simufilam in Patients With Mild-to-Moderate Alzheimer’s
Cassava Sciences正在進行兩項隨機、安慰劑對照的3期臨床試驗,研究口服Simufilam治療輕至中度阿爾茨海默症患者。
Cassava Sciences: Conducting Two Randomized, Placebo-Controlled Phase 3 Clinical Trials Oral Simufilam in Patients With Mild-to-Moderate Alzheimer’s
Cassava Sciences正在進行兩項隨機、安慰劑對照的3期臨床試驗,研究口服Simufilam治療輕至中度阿爾茨海默症患者。
譯文內容由第三人軟體翻譯。